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ABSTRACT 
A 69-year-old patient, with a long history of lung tuberculosis, with lymphopenia was 
emergently admitted in our hospital for bronchopneumonia, ventriculitis, acute 
internal hydrocephalic. He was aggressively treated with iv Meropenem and 
Vancomycin, intraventricular high doses of Vancomycin, aerosols, Dexametazone 
with healing of internal hydrocephalus, ventriculitis and improvement of 
bronchopneumonia.
OBJECT 
The international data in the literature regarding the treatment of 
ventriculitis is limited. The authors aimed to share their experience  in 
the treatment of ventriculitis and using intraventricular (IVT) and 
intravenous antibiotherapy. 
 
CASE REPORT 
The patient was a 69 year-old man, with a previous history of lung 
tuberculosis. He was adressed to the emergency department for 2 days 
of fever (39 degrees C),  4 days of  productive cough with purulent 
expectoration, dyspnea with tachypnea, respiratory failure (SPO2 87%), 
altered mental status (stupor, GCS 10 ), neck stifness. The patient was 
treated by his family doctor with oral cefuroxyme , 4 grams daily . The 
patient was imunodepressed (lymphocytes  470/microliter) 
Chest X-rays and CT scan revealed bronchopneumonia (Fig. 1)  
Head CT Scann:  Acute hidrocephalus, ventriculitis, parafluid 
purulent deposits in occipital horns, bilateral. (Fig 2 - blue arrows) 
The lumbar puncture revealed a purulent CSF with 4690 white 
cells/mm3, 92%  of neutrophils.  
The patient underwent emergency surgery,  extraventricular 
drainage  (EVD) with double purpose:  treatment of acute 
hydrocephalus and  treatment of ventriculitis. The ventricular CSF 
samples were  purulent.  For this reason we considered unnecesarry a 
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complementary head MRI scan. Bacteriologic 
examination  of the CSF revealed: Streptococcus 
pneumoniae. Intravenous antibiotherapy  with 
Meropenem 6  grams/day and Vancomycin  2 grams 
/day, intraventricular antibiotics (Vancomycin 50 
mg/day in the first postoperative day  and 100 
mg/day in the following days), iv Dexametasone (6 
mg q 6 hours), aerosols with  salbutamol 5mg/ml, 1 
ml. After  22 days of treatment, control CT Scann 
revealed disappearance of the acute hydrocephalus 
and the occipital purulent debris (Fig 3). 
 
 
 
Figure 1. Bronchopneumonia. Multiple perihilar opacities, 
bilateral. 
 
Figure 2. 
 
 
 
 
Figure 3. Postoperative contrast  CT Scann. No internal 
hidrocephalus, no ventriculitis. Moderate ventriculomegaly. 
 
The neurological status of the patient progressively 
improved and the neck stiffness dissapeared, also 
the respiratory status improved.  
Follow time period: 5 months 
 
DISCUSSION 
Ventriculitis is defined by high fever, clinical signs of 
meningitis (nuchal rigidity, photophobia, decreased 
mental status, seizures), a positive CSF culture, 
positive Gram stain, decreased CSF  glucose, 
increased  CSF proteins, CSF pleocytosis (at least 11 
leukocytisis/mL with 50% or more 
polymorphonuclear neutrophils) 1,2 In the pre-
antibiotic era, the great majority of patients died 
from bacterial meningitis/ventriculitis at the end of 
the first week of ventriculitis3. Nowadays, the 
incidence of this complication lowered. Central 
nervous system infections requiring treatment with 
intraventricular (IVT) vancomycin are becoming 
increasingly common with advent of intracranial 
devices and increasing prevalence of multi-drug 
resistant and nosocomial organisms4. Administering 
vancomycin via IVT route bypasses the blood-brain 
barrier and allows controlled delivery directly to the 
desired site of action, achieving higher 
concentrations for a more reliable bactericidal 
action4. Indications for IVT vancomycin include 
meningitis unresponsive to intravenous antibiotics, 
ventriculitis, and intracranial device infections4. 
Recommended dosages of antimicrobial agents 
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administered by the intraventricular route are 
vancomycin (5–20 mg/d). Dosages reported in 
literature ranged from 0.075-50 mg/day, with the 
most evidence for dosages of 5 to 20 mg/day. 
Duration of therapy most commonly ranged from 7 
to 21 days4. For this patient, considering the 
imunodepression, bronchopneumonia, ventriculitis  
our option was to administer a higher dose of IVT 
Vancomycine.The patient received aditional 
dexamethasone according to current guidelines, as 
soon as possible when the lumbar puncture reveals 
a purulent CSF 6. Such a treatment has been proven 
to be beneficial in preventing hearing loss and 
neurological sequelae in adult purulent bacterial 
meningitis, particularly those due to Streptococcus 
pneumoniae6,7 
The mean time to obtain CSF sterilisation in 
medical literature was 24hours. This time was 
achieved in this case too. The fever disapeared in the 
first postoperative day. 
There were no adverse effect of antibiotics 
administered IVT. 
 
CONCLUSION 
Intraventricular and intravenous antibiotics lead very 
quickly to CSF sterilisation in this critical ill patient.  
THE IVT vancomicyne administration  appears to 
be safe and have high efficacy together with IV 
administration of Vancomicyn and Meropenem. 
The IVT Vancomycin dose , higher  than the 
literature data, dramaticaly  hastened the healing of 
ventriculitis and shortened the hospitalisation period 
of the patient.  
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